Vor Biopharma
Latest round
- Series B
Last raised
- Jun 2020
Total raised
- $152M
Investors
- 9
About Vor Biopharma
Based in Massachusetts, US, Vor Biopharma, Inc. operates as a biotechnology company founded by Robert Ang. The company develops cell therapy for patients suffering from hematological malignancies. In March 2026, TCG Crossover Management agreed to acquire Vor Biopharma, Inc.05 per share, in a PIPE transaction.
Who invested in Vor Biopharma
9 investors across 2 rounds
See all investors in Vor Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vor Biopharma
Who invested in Vor Biopharma?
Vor Biopharma has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vor Biopharma raised?
Vor Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vor Biopharma last raise money?
Vor Biopharma's most recent round on record is a Series B, in Jun 2020.
What does Vor Biopharma do?
Based in Massachusetts, US, Vor Biopharma, Inc.
Where is Vor Biopharma headquartered?
Vor Biopharma is headquartered in Boston, US.
Which VCs invest in companies like Vor Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vor Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vor Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.